- Global Pharma News & Resources

Helicobacter Pylori Diagnostics Market Growth To Be Driven By The Increasing Number Of Cases For H. Pylori Infection

Pune, Maharashtra, Jun 13, 2019 (Wired Release) Prudour Pvt. Ltd. – Helicobacter pylori or H. pylori is a gram-negative and spiral microorganism. It is responsible for colonization in the gastric microniche. These diagnostics techniques include malignancies and non-malignant conditions such as non-ulcer dyspepsia, peptic ulcers, recurrent peptic ulcer bleeding, idiopathic thrombocytopaenia, purpura, colorectal adenomas, and unexplained iron deficiency anaemia. The diagnosis is confirmed by endoscopic biopsy, and then histopathological examination by using eosin and haemotoxylin (H and E) stain or special stains such as Warthin-Starry stain and Giemsa stain.

Increasing prevalence of H. pylori infections is a major factor propelling the global H. pylori diagnostics market during the forecasted period. These types of infections are occurring generally in developing countries, due to poor sanitation, lack of water supply, poor personal hygiene. However, stringent regulatory norms and rules by the government are factors expected to hamper the market growth to a certain extent.

There are two types of Helicobacter pylori diagnostics namely invasive techniques and non-invasive techniques. The non-invasive techniques include urine or blood detection of H. pylori antigen in stool specimen, urea breath test, and serology. The non-invasive technique is widely recommended in the primary care setting. Invasive techniques include endoscopy and biopsy such as histological examination and rapid urease test. The choice of technique depends on the infection, characteristics of the test being used, its cost.

By application, the market is mainly divided into hospitals and clinics and diagnostic laboratories. These tests are widely carried out hospitals and clinics, owing to the availability of advanced technique and well-equipment infrastructure for carrying out a test procedure.

Based on regions, the market has been further categories across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these regions, the demand for Helicobacter pylori diagnostics is significantly high in counties of North America region. This can be attributed to increasing incidences of peptic ulcer, which may lead to severe complications such as internal bleeding, obstruction, and intestine infection. Asia Pacific region is expected to contribute to the highest growth rate for Helicobacter pylori diagnostics, owing to the increasing number of geriatric population and increasing awareness about these infections among people.

Key players are receiving approvals for their products in order to enhance product offering as well as expand its presence. For instance, in August 2018, TECHLAB, Inc., which is a US-based company that manufacturers of rapid non-invasive diagnostic tests for gastrointestinal diseases – received USFDA clearance for the H. PYLORI CHEK tests and H. PYLORI QUIK CHEK test– which are intended to help in detection and diagnosis of H. pylori infection.

Some of the key players profiled in the global helicobacter pylori diagnostics market report includes F. Hoffmann-La Roche, Sekisui Diagnostics, Meridian Bioscience, Quidel, Halyard Health Inc, Thermo Fisher Scientific, Medline Industries, Alpha Laboratories, Bio-Rad Laboratories, EKF Diagnostics, Cardinal Health, Agilent Technologies, Coris BioConcept, Beckman Coulter Inc.


Editor Details

Last Updated: 13-Jun-2019